Merck (MRK) Short term Debt (2009 - 2026)
Merck (MRK) posted quarterly Short term Debt of $2.4 billion for Q1 2026, up 79.71% year-over-year from $1.4 billion in Q1 2025, and down 5.6% quarter-over-quarter from $2.6 billion in Q4 2025.
Merck (MRK) Short term Debt (2009 - 2026) Analysis & Trends
Merck (MRK) has reported Short term Debt for 18 consecutive years, with $2.4 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Short term Debt rose 79.71% year-over-year to $2.4 billion; the TTM figure through Mar 2026 stood at $2.4 billion (up 79.71% YoY), while the FY2025 annual figure was $2.6 billion, down 2.27% from the prior year.
- Short term Debt retreated to $2.4 billion in Q1 2026 per MRK's latest filing, from $2.6 billion in the prior quarter.
- Across five years, Short term Debt topped out at $3.1 billion in Q3 2024 and bottomed at $887.0 million in Q3 2023.
- Historically, Short term Debt has averaged $2.2 billion across 5 years, with a median of $2.4 billion in 2026.
- Annual changes were most pronounced in 2022 — Short term Debt plunged 83.34% — and 2024, when it jumped 255.02%.
- Merck's Short term Debt stood at $1.9 billion in 2022, then slipped by 29.5% to $1.4 billion in 2023, then soared by 93.08% to $2.6 billion in 2024, then retreated by 2.27% to $2.6 billion in 2025, then declined by 5.6% to $2.4 billion in 2026.
- Business Quant data shows MRK's Short term Debt at $2.4 billion in Q1 2026, $2.6 billion in Q4 2025, and $1.4 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.95 Bn | 632.19 Bn | 17.26 Bn |
| 2 | AbbVie | 469.97 Bn | 463.40 Bn | 12.70 Bn |
| 3 | Merck | 377.05 Bn | 369.90 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.66 Bn | 294.97 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.09 Bn | 253.19 Bn | 12.86 Bn |
| 6 | Amgen | 236.99 Bn | 223.00 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 183.08 Bn | 179.90 Bn | 6.22 Bn |
| 8 | Pfizer | 160.54 Bn | 148.84 Bn | 10.94 Bn |
| 9 | Gsk | 106.06 Bn | 101.89 Bn | 8.24 Bn |
| 10 | Sanofi | 55.32 Bn | 47.94 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.83 Bn |
| Mar 31, 2026 | 2.44 Bn |
| Dec 31, 2025 | 2.59 Bn |
| Sep 30, 2025 | 1.41 Bn |
| Jun 30, 2025 | 1.43 Bn |
| Mar 31, 2025 | 1.36 Bn |
| Dec 31, 2024 | 2.65 Bn |
| Sep 30, 2024 | 3.15 Bn |
| Jun 30, 2024 | 3.07 Bn |
| Mar 31, 2024 | 3.08 Bn |
| Dec 31, 2023 | 1.37 Bn |
| Sep 30, 2023 | 887.00 Mn |
| Jun 30, 2023 | 2.84 Bn |
| Mar 31, 2023 | 2.67 Bn |
| Dec 31, 2022 | 1.95 Bn |
| Sep 30, 2022 | 1.94 Bn |
| Jun 30, 2022 | 2.98 Bn |
| Mar 31, 2022 | 1.21 Bn |
| Dec 31, 2021 | 2.41 Bn |
| Sep 30, 2021 | 3.53 Bn |